316 related articles for article (PubMed ID: 23349132)
21. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
22. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
23. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
24. Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis.
Laivoranta-Nyman S; Möttönen T; Hannonen P; Korpela M; Kautiainen H; Leirisalo-Repo M; Julkunen H; Luukkainen R; Hakala M; Vuori K; Laine AP; Toivanen A; Ilonen J;
Clin Exp Rheumatol; 2006; 24(6):636-42. PubMed ID: 17207378
[TBL] [Abstract][Full Text] [Related]
25. Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Ganu MA; Ganu AS
J Assoc Physicians India; 2011 Feb; 59():83-6. PubMed ID: 21751641
[TBL] [Abstract][Full Text] [Related]
26. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial.
Rantalaiho V; Kautiainen H; Korpela M; Hannonen P; Kaipiainen-Seppänen O; Möttönen T; Kauppi M; Karjalainen A; Laiho K; Laasonen L; Hakola M; Peltomaa R; Leirisalo-Repo M;
Ann Rheum Dis; 2014 Nov; 73(11):1954-61. PubMed ID: 23908187
[TBL] [Abstract][Full Text] [Related]
27. Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort.
McWilliams DF; Kiely PD; Young A; Walsh DA
BMC Musculoskelet Disord; 2013 May; 14():153. PubMed ID: 23634781
[TBL] [Abstract][Full Text] [Related]
28. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
29. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
30. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
31. Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience.
Shiroky JB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():109-12. PubMed ID: 8535641
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
van Vollenhoven RF; Chatzidionysiou K
Nat Rev Rheumatol; 2013 Sep; 9(9):510-2. PubMed ID: 23897440
[TBL] [Abstract][Full Text] [Related]
33. [Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].
Duodecim; 2015; 131(15):1409-10. PubMed ID: 26433976
[TBL] [Abstract][Full Text] [Related]
34. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
Haagsma CJ; van Riel PL; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():104-8. PubMed ID: 8535640
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid arthritis: new developments in the use of existing therapies.
O'Dell JR; Scott DL
Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():24-6. PubMed ID: 10646486
[TBL] [Abstract][Full Text] [Related]
36. Rheumatoid arthritis.
Emery P; Suarez-Almazor M
Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
[No Abstract] [Full Text] [Related]
37. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.
Calgüneri M; Pay S; Calişkaner Z; Apraş S; Kiraz S; Ertenli I; Cobankara V
Clin Exp Rheumatol; 1999; 17(6):699-704. PubMed ID: 10609068
[TBL] [Abstract][Full Text] [Related]
38. Improving patient-centred care for rheumatoid arthritis.
Bansback N; Shojania K; Lacaille D
CMAJ; 2016 Oct; 188(14):999-1000. PubMed ID: 27354676
[No Abstract] [Full Text] [Related]
39. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
40. Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.
Bergstra SA; Allaart CF; Ramiro S; Chopra A; Govind N; Silva C; Murphy EA; Landewé RBM
J Rheumatol; 2018 Oct; 45(10):1361-1366. PubMed ID: 29907672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
